Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 169,234 |
|
|||||
| News | - | ||||||
| Day High | 0.7264 | Low High |
|||||
| Day Low | 0.68 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cara Therapeutics Inc | CARA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0157 | -2.24% | 0.6843 | 17:11:01 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.69 | 0.68 | 0.7264 | 0.6843 | 0.70 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,393 | 169,234 | US$ 0.7099292 | US$ 120,144 | - | 0.50 - 4.6699 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:20:01 | formt | 386 | US$ 0.6843 | USD |
Cara Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 37.17M | 54.66M | - | 20.97M | -118.51M | -2.17 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cara Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CARA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.685 | 0.7394 | 0.64 | 0.6942739 | 280,808 | -0.0007 | -0.10% |
| 1 Month | 0.9114 | 0.949 | 0.6311 | 0.7797853 | 339,092 | -0.2271 | -24.92% |
| 3 Months | 0.5499 | 1.15 | 0.515 | 0.8221559 | 639,070 | 0.1344 | 24.44% |
| 6 Months | 1.23 | 1.40 | 0.50 | 0.8212183 | 713,192 | -0.5457 | -44.37% |
| 1 Year | 3.93 | 4.6699 | 0.50 | 2.09 | 864,464 | -3.25 | -82.59% |
| 3 Years | 26.40 | 27.07 | 0.50 | 8.33 | 760,021 | -25.72 | -97.41% |
| 5 Years | 19.38 | 29.6473 | 0.50 | 12.18 | 701,808 | -18.70 | -96.47% |
Cara Therapeutics Description
| Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features. |
